The conference presentations are now available for download.

Open the program by clicking the button below and then hover over the name of the Presenter. 

Please note not all Presenters have given permission to share their presentations.


Presentation Download


On behalf of the ANZGOG Organising Committee, we invite you to take part in the 2016 ANZGOG Annual Scientific Meeting.

Four very distinguished international speakers will be providing keynote address across all three key specialities of surgical, medical and radiation therapy. We also have an outstanding array of speakers from Australia and New Zealand.

Inspired by the theme “New Targets and Better Outcomes for Women with Gynaecological Cancer”, the ASM will also host our second Pure Science Symposium which this year will be held on Saturday afternoon, providing more opportunity for all to attend.

The 2.5 days of scientific program will include a range of workshops including Concept Development, Radiation Oncology, and specialty interests for Study Coordinators, Consumers and Gynaecological Nurses.

Due to growth in attendance and ANZGOG membership to 710 specialists in gynaecological oncology, the meeting will be held in Sydney in 2016, providing a greater opportunity for members to get involved.

We encourage you to attend as many sessions as possible, to network and share knowledge and foster new collaborations. 

We would like to thank members of the ANZGOG Scientific Meeting Program committee for their commitment, helping to organise the Annual Scientific Meeting 2016. 

This is also an outstanding event for industry to show their support for ANZGOG. Their assistance helps make this event a success.

We wish you all a stimulating, educational and rewarding meeting.        

Kind Regards


Associate Professor Peter Sykes                        Associate Professor Alison Brand
ASM Committee Chair                                           ANZGOG Chair


ANZGOG ASM Chair - Peter Sykes

ANZGOG Chair – Alison Brand
Research Advisory Committee – Alison Davis
Medonc NSW – Diana Adams
Medonc/QoL NSW – Kate Webber
Medonc VIC –Sumitra Ananda
Medonc QLD – Jeff Goh
Medonc SA – Ganessan  Kichenadasse
Gynonc NSW – Rhonda Farrell
Gynonc WA – Raj Ganendra
Radonc VIC – Pearly Khaw
Radonc NSW – Viet Do
Translational Research – Clare Scott
Translational Research – Pamela Pollock
Study Coordinators – Sue Brew 
ANZGOG Executive Officer:  Alison Evans
Professional Conference Organiser:  YRD Ltd – Kate Murphy 


Christian Marth - Gynaecologist Oncologist

Christian Marth, MD, PhD, is the Director of the Department of Obstetrics & Gynecology Innsbruck, Austria. 

Christian Marth received his medical degree from the Leopold Franzens University of Innsbruck, Faculty of Medicine, in 1985, performed his residency in gynecology & obstetrics from 1985-1991, registered as a fellow in obstetrics & gynecology in 1991, and completed his habilitation and was awarded venia legendi in gynecology and obstetrics with the thesis “Biological modulators in ovarian cancer” from the University Innsbruck in 1991.

From 1996 – 1998 Christian Marth was senior physician at Det Norske Radiumhospital in Oslo (Norway). Since October 1998 he is the director of the Department of Obstetrics and Gynecology at the University Hospital Innsbruck.

Christian Marth is a member of many medical societies, including the European Society of Gynecologic Oncology (ESGO), the International Society of Gynecologic Cancer (IGCS), the American Society of Clinical Oncology (ASCO), the Austrian Society of Gynecology and Obstetrics (OEGGG). He is an executive board member of the Gynecologic Cancer Intergroup (GCIG). Actually he is the president of the ENGOT and of the Austrian Association for Gynecologic Oncology (AGO), vice president of the ABCSG (Austrian Breast and Colorectal Cancer Study Group).

Christian Marth has been the author or co-author of more than 340 scientific articles, reviews, and book chapters. He received 13 national and international awards.

Anuja Jhingran: Radiation Oncologist

ANUJA JHINGRAN, M.D., FACR Professor of Radiation Oncology The University of Texas MD Anderson Cancer Center Houston, TX Dr.

Anuja Jhingran earned her M.D. at Texas Tech University in 1988, followed by residency training at Baylor College of Medicine in Internal Medicine and Radiation Oncology. She began her career as an Assistant Professor at The University of Texas MD Anderson Cancer Center in 1996 and has advanced to a Professor of Radiation Oncology in the Section of Gynecology. She is a physician specializing in the treatment of gynecologic cancers. Clinically, she is interested in the management of advanced ovarian, cervical, and endometrial cancers and the use of advanced radiation techniques to minimize toxicity. In addition, Dr. Jhingran is heavily involved with the Radiation Therapy Oncology Group (RTOG) and Gynecologic Oncology Group (GOG) in the development of patient care studies to treat gynecologic cancers and is the national Principal Investigator of several accruing studies including a phase III study in cervical cancer. Dr. Jhingran travels extensively internationally for cancer education. She is passionate about women’s health issues and especially as it relates to developing country’s efforts to establish improved health care for the general populace, not just the financially able.

Michael Birrer: Medical Oncologist

Dr. Birrer earned his undergraduate degree at Rensselaer Polytechnic Institute and graduated with a B.S. in Biology.  He subsequently was accepted into the Medical Scientist Training Program at the Albert Einstein College of Medicine and completed his M.D. and Ph.D. in 1982 with his principle area of study in microbiology and immunology.  He performed a medical internship at the Massachusetts General Hospital (MGH) and subsequently completed a residency in medicine at MGH.  Dr. Birrer entered the medical oncology fellowship at the National Cancer Institute in Bethesda, Maryland and upon completion performed a postdoctoral fellowship in the laboratory of Dr. John Minna on the molecular genetics of lung cancer.  After completing his fellowship, Dr. Birrer joined the faculty at the NCI in the Division of Cancer Treatment as an investigator in 1988.  Three years later, Dr. Birrer was appointed as a senior investigator (with tenure) and established the molecular mechanism section in the Division of Cancer Prevention and Control.  Over the next 17 years, Dr. Birrer held a number of positions including the Committee for the Protection of Human Subjects, Gynecologic Oncology Tumor Board, Extramural IRB, Clinical Oncology Fellowship Section Committee, Chair of the Gynecologic Oncology Working Group in the Division of Clinical Sciences and Deputy Branch Chief of the Cell and Cancer Biology Branch.

Dr. Birrer is recognized nationally and internationally as an expert in gynecologic oncology.  He has published over 270 peer reviewed manuscripts and another 27 book chapters and review articles.  He has served in leadership positions within the greater gynecologic oncology community.  He has been the Chair and Chair Emeritus of the DOD Ovarian Cancer Research Program, Chair of the Committee for Experimental Medicine of the Gynecologic Oncology Group, a member of the Gynecologic Cancer Steering Committee and Chair of the Translational Science Working Group of the Gynecologic Cancer Intergroup.  Dr. Birrer has been a member of the Society of Gynecologic Oncology, American Society of Clinical Oncologists, American Association of Cancer Research and the International Gynecologic Cancer Society.  He has been on the program committees of ASCO, SGO and IGCS.

In November 2008, Dr. Birrer was appointed Professor of Medicine at the Harvard School of Medicine.  Dr. Birrer assumed the position of Director of Gynecologic Medical Oncology at MGH and the Gynecologic Oncology Research Program.  This program integrates important new discoveries in translational research into clinical trials.

Susana Banerjee: Medical Oncologist

Dr Susana Banerjee is a Consultant Medical Oncologist at the Royal Marsden specialising in the treatment of patients with ovarian cancers and other gynaecological cancers.  She is the Research Lead for the Royal Marsden Gynaecology Unit and Associate Honorary Faculty at the Institute of Cancer Research.

Dr. Banerjee graduated with a first class from St John’s College, the University of Cambridge and completed her medical training at Royal Free Medical School where she was a University of London Gold Medal Finalist. Dr Banerjee was awarded an Avon Breast Cancer Crusade Clinical Fellowship for laboratory research and gained a PhD from the Institute of Cancer Research, University of London.

Dr Banerjee is a member of the National Cancer Research Institute (NCRI) ovarian and cervical cancer subgroups and Research Co-Lead for the London Cancer Alliance Gynaecological Cancers Group. She is a member of the European Society of Medical Oncology (ESMO) Young Oncologists' Committee, ESMO Gynaecological Cancers Faculty and a Key Opinion Leader for the ‘Women 4 Oncology’ ESMO initiative. She has published over 30 articles in peer-reviewed journals and book chapters and lectures at international meetings.

Dr Banerjee is actively involved in clinical trials and translational research. Her research interests are individualisation of patient treatment and targeted therapies in women's cancers.



Astra Zeneca Evening Symposium 

Patient outcomes in focus: Selection and treatment in BRCAm ovarian cancer.



Arrival: drinks and canapes



Welcome and introduction
Patient outcomes in focus: Selection and treatment in BRCAm ovarian cancer.

Michael Quinn


Identifying the patient: Challenges in BRCA testing and patient diagnosis

Christian Marth


Optimal treatment of BRCA mutated relapsed ovarian cancer

Susana Banerjee



Chair, faculty and audience








Deadline for Abstract Submission: 7th March 2016
Authors notified via email: 18th March 2016
Oral Presentation at the ASM 2016: Thursday 14th April
Poster Presentation at the ASM 2016: 14th -16th April 




Deadline for Concept Submission: 7th March 2016
Applicants notified via email: 18th March 2016
Presentation of Concept at ASM: Thursday 14th April 




Recent publication of the ASTRO Guidelines, in conjunction with ASCO, has resulted in a streamlined management for Endometrial Cancer. These guidelines were based on current published data detailing “best practice” for each stage of disease. There are areas in the guidelines that may be considered “controversial” and not necessarily accepted “standard of care” in ANZ.

The Workshop this year will have the presence of A/Prof Anuja Jhingran who has been involved in the development of these Guidelines. She will be able to provide us with information on the formulation of the Guidelines and it’s acceptance in the US.

All Radiation Oncologists and other interested parties are invited to attend the workshop, and participate in a robust discussion on the Guideline and determine if they are acceptable for ANZ. Amendments can then be discussed and included accordingly.

At the conclusion of this Workshop we hope to be able to have a set of Guidelines available for discussion amongst the wider Gynae-Oncology community. From there it will be possible to have these Guidelines endorsed and adopted in ANZ.

Please make yourself available to participate in this very important Workshop.


Work on your idea with leading researchers

Bring a one sentence or single paragraph ideas for development.  We have places for a maximum of 16 researchers with a concept idea to develop further at the workshop.  Please confirm your workshop registration ASAP as spaces filling fast.  Send in your idea to Heshani Nesfield at  by Friday 8 April 2016.  


Martin Stockler will guide you on how to structure a concept outline and share the Research Advisory Committee peer review process to get an outline into the ANZGOG mix. Linda Mileshkin will go through Peer Review by the Research Advisory Group and working with the Tumour Type Working Groups.  Yoland Antill will speak about her experience developing a Phase II study and working with pharma.  Peter Sykes will discuss the ANZGOG New Research Fund grants.   

You will get to discuss your concept in small groups with two clinical advisers and a statistician as well as with other clinical specialists who will be in attendance to assist.  



A focus on Gynaecological Cancer Nurses

Dr Catherine Adams, a Psycho Oncologist at the John Hunter Hospital will guide you on ‘Resilience and Self Care’ an education on maintaining a healthy life balance.  A study conducted by Olivia Cook on Specialist Nurses in Gynaecological Cancer will also be shared for discussion and insight.  Anne Mellon will lead a discussion on the future of cervical screening in Australia.


Developing SOPs for your Site

Sally Dean will lead this workshop which will give you a head start on developing Standard Operating Procedures for your site.  Sally has worked with Eleanor Allan to develop the SOPs for the Hunter Clinical Cancer Network.





 Intercontinental Sydney 
Double Bay

Classic Room $265.00
Check in: 3pm

Check out: 11am 





Double Bay

Studio Room $199.00
Check in: 3pm

Check out: 11am 






Double Bay

2 Bedroom Apartment $299.00
Check in: 3pm
Check out: 11am 


Located in the picturesque bayside village of Double Bay, this intimate Sydney hotel offers luxury and privacy at its finest with first class conference facilities. Only minutes from the CBD of Sydney and 13kms from the airport, guests can enjoy the central location and village atmosphere of Double Bay with boutique shopping, cafes and harbour sidewalks only minutes from the hotel.